ProPhase Labs, Inc.
PRPH
$0.3326
$0.00130.39%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 218.66% | -138.33% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 218.66% | -138.33% | |||
| Cost of Revenue | 151.51% | -153.07% | |||
| Gross Profit | -4.54% | 433.94% | |||
| SG&A Expenses | -73.98% | 105.54% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -63.69% | 26.57% | |||
| Operating Income | 75.96% | -91.94% | |||
| Income Before Tax | 72.00% | -83.67% | |||
| Income Tax Expenses | -- | 680.38% | |||
| Earnings from Continuing Operations | 85.04% | -374.59% | |||
| Earnings from Discontinued Operations | 379.02% | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 111.54% | -421.62% | |||
| EBIT | 75.96% | -91.94% | |||
| EBITDA | 85.12% | -164.27% | |||
| EPS Basic | 107.08% | -360.57% | |||
| Normalized Basic EPS | 82.28% | -42.63% | |||
| EPS Diluted | 107.12% | -351.63% | |||
| Normalized Diluted EPS | 82.28% | -42.63% | |||
| Average Basic Shares Outstanding | 72.18% | 7.25% | |||
| Average Diluted Shares Outstanding | 72.18% | 7.25% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||